Background: Myocardial injury was a frequent cardiovascular manifestation of COVID-19
and associated with high mortality. Cell-based approaches, primarily using mesenchymal …

Abstract Coronavirus Disease-19 (COVID-19) has become a global pandemic that affected
the lives of billion individuals. The clinical spectrum of the disease varies from asymptomatic …

One of the main causes of acute respiratory distress syndrome in coronavirus disease 2019
(COVID-19) is cytokine storm, although the exact cause is still unknown. Umbilical cord …

Objective Treatment for COVID-19 is still urgent need for the critically ill and severe cases.
UC-MSC administration has a therapeutic benefit for severe COVID-19 patients even in the …

Background: Mesenchymal stem cells can serve as a therapeutic option for COVID-19. Their
immunomodulatory and anti-inflammatory properties can regulate the exaggerated …

Objective: Mesenchymal stem cells can serve as a therapeutic option for COVID-19. Their
immunomodulatory and anti-inflammatory properties can regulate the exaggerated …

Abstract Context: Coronavirus disease (COVID-19) with severe respiratory morbidity and
mortality, rapidly spread all over the world, caused by an sever acute respiratory syndrome …

OBJECTIVES: The coronavirus disease (COVID-19) outbreak has catastrophically
threatened public health worldwide and presented great challenges for clinicians. To date …

Background The novel coronavirus is still mutating, and the pandemic continues.
Meanwhile, many COVID-19 survivors have residual postinfection clinical manifestations …

Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …